167 related articles for article (PubMed ID: 36748274)
1. Cholesterol-Amino-Phosphate (CAP) Derived Lipid Nanoparticles for Delivery of Self-Amplifying RNA and Restoration of Spermatogenesis in Infertile Mice.
Du S; Li W; Zhang Y; Xue Y; Hou X; Yan J; Cheng J; Deng B; McComb DW; Lin J; Zeng H; Cheng X; Irvine DJ; Weiss R; Dong Y
Adv Sci (Weinh); 2023 Apr; 10(11):e2300188. PubMed ID: 36748274
[TBL] [Abstract][Full Text] [Related]
2. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
[TBL] [Abstract][Full Text] [Related]
3. The role of tyrosine phosphatase Shp2 in spermatogonial differentiation and spermatocyte meiosis.
Li Y; Liu WS; Yi J; Kong SB; Ding JC; Zhao YN; Tian YP; Feng GS; Li CJ; Liu W; Wang HB; Lu ZX
Asian J Androl; 2020; 22(1):79-87. PubMed ID: 31210146
[TBL] [Abstract][Full Text] [Related]
4. Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA.
Blakney AK; McKay PF; Yus BI; Aldon Y; Shattock RJ
Gene Ther; 2019 Sep; 26(9):363-372. PubMed ID: 31300730
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens.
Snoeck J; Chiers K; Tam Y; Sanders NN; Garmyn A
Poult Sci; 2023 Nov; 102(11):103078. PubMed ID: 37801866
[TBL] [Abstract][Full Text] [Related]
6. Optimization of Lipid Nanoparticles for saRNA Expression and Cellular Activation Using a Design-of-Experiment Approach.
Ly HH; Daniel S; Soriano SKV; Kis Z; Blakney AK
Mol Pharm; 2022 Jun; 19(6):1892-1905. PubMed ID: 35604765
[TBL] [Abstract][Full Text] [Related]
7. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
8. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency.
Anderluzzi G; Lou G; Woods S; Schmidt ST; Gallorini S; Brazzoli M; Johnson R; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y
J Control Release; 2022 Feb; 342():388-399. PubMed ID: 34896446
[TBL] [Abstract][Full Text] [Related]
9. Ionizable lipid nanoparticles for in utero mRNA delivery.
Riley RS; Kashyap MV; Billingsley MM; White B; Alameh MG; Bose SK; Zoltick PW; Li H; Zhang R; Cheng AY; Weissman D; Peranteau WH; Mitchell MJ
Sci Adv; 2021 Jan; 7(3):. PubMed ID: 33523869
[TBL] [Abstract][Full Text] [Related]
10. An ENU-induced mutation in the mouse Rnf212 gene is associated with male meiotic failure and infertility.
Fujiwara Y; Matsumoto H; Akiyama K; Srivastava A; Chikushi M; Ann Handel M; Kunieda T
Reproduction; 2015 Jan; 149(1):67-74. PubMed ID: 25342176
[TBL] [Abstract][Full Text] [Related]
11. Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines.
Kairuz D; Samudh N; Ely A; Arbuthnot P; Bloom K
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111658
[TBL] [Abstract][Full Text] [Related]
12. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
Wang C; Zhang Y; Dong Y
Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
[TBL] [Abstract][Full Text] [Related]
13. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles.
Yanez Arteta M; Kjellman T; Bartesaghi S; Wallin S; Wu X; Kvist AJ; Dabkowska A; Székely N; Radulescu A; Bergenholtz J; Lindfors L
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3351-E3360. PubMed ID: 29588418
[TBL] [Abstract][Full Text] [Related]
14. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
[TBL] [Abstract][Full Text] [Related]
15. Advanced nanoscale delivery systems for mRNA-based vaccines.
Mobasher M; Ansari R; Castejon AM; Barar J; Omidi Y
Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130558. PubMed ID: 38185238
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy.
Escalona-Rayo O; Zeng Y; Knol RA; Kock TJF; Aschmann D; Slütter B; Kros A
Biomed Pharmacother; 2023 Sep; 165():115065. PubMed ID: 37406506
[TBL] [Abstract][Full Text] [Related]
17. Novel Ionizable Lipid Nanoparticles for SARS-CoV-2 Omicron mRNA Delivery.
Long J; Yu C; Zhang H; Cao Y; Sang Y; Lu H; Zhang Z; Wang X; Wang H; Song G; Yang J; Wang S
Adv Healthc Mater; 2023 May; 12(13):e2202590. PubMed ID: 36716702
[TBL] [Abstract][Full Text] [Related]
18. Optimization of Lipid Nanoformulations for Effective mRNA Delivery.
Chen H; Ren X; Xu S; Zhang D; Han T
Int J Nanomedicine; 2022; 17():2893-2905. PubMed ID: 35814615
[TBL] [Abstract][Full Text] [Related]
19. Effect of Cholesterol Content of Lipid Composition in mRNA-LNPs on the Protein Expression in the Injected Site and Liver After Local Administration in Mice.
Kawaguchi M; Noda M; Ono A; Kamiya M; Matsumoto M; Tsurumaru M; Mizukami S; Mukai H; Kawakami S
J Pharm Sci; 2023 May; 112(5):1401-1410. PubMed ID: 36596392
[TBL] [Abstract][Full Text] [Related]
20. Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA.
Miao H; Huang K; Li Y; Li R; Zhou X; Shi J; Tong Z; Sun Z; Yu A
Int J Pharm; 2023 Jun; 640():123050. PubMed ID: 37201764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
